Literature DB >> 31064741

Using out-of-office blood pressure measurements in established cardiovascular risk scores: a secondary analysis of data from two blood pressure monitoring studies.

Sarah Lay-Flurrie1, Richard Stevens1, Peter de Leeuw2, Abraham Kroon2, Sheila Greenfield3, Mohammed Mohammed4, Paramjit Gill5, Willem Verberk2, Richard McManus1.   

Abstract

BACKGROUND: Blood pressure (BP) measurement is increasingly carried out through home or ambulatory monitoring, yet existing cardiovascular risk scores were developed for use with measurements obtained in clinics. AIM: To describe differences in cardiovascular risk estimates obtained using ambulatory or home BP measurements instead of clinic readings. DESIGN AND
SETTING: Secondary analysis of data from adults aged 25-84 years in the UK and the Netherlands without prior history of cardiovascular disease (CVD) in two BP monitoring studies: the Blood Pressure in different Ethnic groups (BP-Eth) study and the Home versus Office blood pressure MEasurements: Reduction of Unnecessary treatment Study (HOMERUS).
METHOD: The primary comparison was Framingham risk calculated using BP measured as in the Framingham study or daytime ambulatory BP measurements. Statistical significance was determined using non-parametric tests.
RESULTS: In 442 BP-Eth patients (mean age = 58 years, 50% female [n = 222]) the median absolute difference in 10-year Framingham cardiovascular risk calculated using BP measured as in the Framingham study or daytime ambulatory BP measurements was 1.84% (interquartile range [IQR] 0.65-3.63, P = 0.67). In 165 HOMERUS patients (mean age = 56 years, 46% female) the median absolute difference in 10-year risk for daytime ambulatory BP was 2.76% (IQR 1.19-6.39, P<0.001) and only 8 out of 165 (4.8%) of patients were reclassified.
CONCLUSION: Estimates of cardiovascular risk are similar when calculated using BP measurements obtained as in the risk score derivation study or through ambulatory monitoring. Further research is required to determine if differences in estimated risk would meaningfully influence risk score accuracy. © British Journal of General Practice 2019.

Entities:  

Keywords:  blood pressure; myocardial infarction; primary health care; risk; stroke

Mesh:

Year:  2019        PMID: 31064741      PMCID: PMC6532811          DOI: 10.3399/bjgp19X702737

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  33 in total

1.  Accuracy of the SpaceLabs Medical 90217 ambulatory blood pressure monitor.

Authors: 
Journal:  Blood Press Monit       Date:  1998-10       Impact factor: 1.444

2.  Comparison of the oscillometric blood pressure monitor (BPM-100(Beta) ) with the auscultatory mercury sphygmomanometer.

Authors:  G S Mattu; T L Perry; J M Wright
Journal:  Blood Press Monit       Date:  2001-06       Impact factor: 1.444

3.  Masked hypertension.

Authors:  Thomas G Pickering; Karina Davidson; William Gerin; Joseph E Schwartz
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 4.  What is the white-coat effect and how should it be measured?

Authors:  Thomas G Pickering; William Gerin; Amy R Schwartz
Journal:  Blood Press Monit       Date:  2002-12       Impact factor: 1.444

5.  Problems in the assessment of blood pressure: the Framingham Study.

Authors:  T Gordon; P Sorlie; W B Kannel
Journal:  Int J Epidemiol       Date:  1976-12       Impact factor: 7.196

6.  White-coat hypertension: a clinical review.

Authors:  Hilde Celis; Robert H Fagard
Journal:  Eur J Intern Med       Date:  2004-10       Impact factor: 4.487

Review 7.  Blood Pressure Monitoring. Task force V: White-coat hypertension.

Authors:  T G Pickering; A Coats; J M Mallion; G Mancia; P Verdecchia
Journal:  Blood Press Monit       Date:  1999-12       Impact factor: 1.444

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Home versus Office blood pressure MEasurements: Reduction of Unnecessary treatment Study: rationale and study design of the HOMERUS trial.

Authors:  W J Verberk; A A Kroon; A G H Kessels; C Dirksen; P J Nelemans; J W M Lenders; Th A B M Thien; G A van Montfrans; A J Smit; P W de Leeuw
Journal:  Blood Press       Date:  2003       Impact factor: 2.835

10.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  2 in total

Review 1.  Clinical applications for out-of-office blood pressure monitoring.

Authors:  Hailan Zhu; Haoxiao Zheng; Xinyue Liu; Weiyi Mai; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2020-01-20       Impact factor: 5.091

2.  The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines.

Authors:  Katy Bell; Jenny Doust; Kevin McGeechan; Andrea Rita Horvath; Alexandra Barratt; Andrew Hayen; Christopher Semsarian; Les Irwig
Journal:  J Hypertens       Date:  2021-02-01       Impact factor: 4.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.